Literature DB >> 33361254

Alzheimer Disease Spectrum: Syndrome and Etiology From Clinical and PET Imaging Perspectives.

David S Knopman1, William J Jagust2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33361254      PMCID： PMC8570920          DOI： 10.1212/WNL.0000000000011415

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  10 in total

1.  Combined neuropathological pathways account for age-related risk of dementia.

Authors:  Melinda C Power; Elizabeth Mormino; Anja Soldan; Bryan D James; Lei Yu; Nicole M Armstrong; Katherine J Bangen; Lisa Delano-Wood; Melissa Lamar; Yen Ying Lim; Kelly Nudelman; Laura Zahodne; Alden L Gross; Dan Mungas; Keith F Widaman; Julie Schneider
Journal:  Ann Neurol       Date:  2018-06-26       Impact factor: 10.422

2.  Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Authors:  Rik Ossenkoppele; Gil D Rabinovici; Ruben Smith; Hanna Cho; Michael Schöll; Olof Strandberg; Sebastian Palmqvist; Niklas Mattsson; Shorena Janelidze; Alexander Santillo; Tomas Ohlsson; Jonas Jögi; Richard Tsai; Renaud La Joie; Joel Kramer; Adam L Boxer; Maria L Gorno-Tempini; Bruce L Miller; Jae Y Choi; Young H Ryu; Chul H Lyoo; Oskar Hansson
Journal:  JAMA       Date:  2018-09-18       Impact factor: 56.272

Review 3.  Mild cognitive impairment: ten years later.

Authors:  Ronald C Petersen; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2009-12

4.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Authors:  Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters
Journal:  Lancet Neurol       Date:  2013-03-08       Impact factor: 44.182

5.  Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

Authors:  Christopher M Clark; Michael J Pontecorvo; Thomas G Beach; Barry J Bedell; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Eric M Reiman; Marwan N Sabbagh; Carl H Sadowsky; Julie A Schneider; Anupa Arora; Alan P Carpenter; Matthew L Flitter; Abhinay D Joshi; Michael J Krautkramer; Ming Lu; Mark A Mintun; Daniel M Skovronsky
Journal:  Lancet Neurol       Date:  2012-06-28       Impact factor: 44.182

6.  Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.

Authors:  Adam S Fleisher; Michael J Pontecorvo; Michael D Devous; Ming Lu; Anupa K Arora; Stephen P Truocchio; Patricia Aldea; Matthew Flitter; Tricia Locascio; Marybeth Devine; Andrew Siderowf; Thomas G Beach; Thomas J Montine; Geidy E Serrano; Craig Curtis; Allison Perrin; Stephen Salloway; Misty Daniel; Charles Wellman; Abhinay D Joshi; David J Irwin; Val J Lowe; William W Seeley; Milos D Ikonomovic; Joseph C Masdeu; Ian Kennedy; Thomas Harris; Michael Navitsky; Sudeepti Southekal; Mark A Mintun
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

7.  Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.

Authors:  Rosebud O Roberts; Jeremiah A Aakre; Walter K Kremers; Maria Vassilaki; David S Knopman; Michelle M Mielke; Rabe Alhurani; Yonas E Geda; Mary M Machulda; Preciosa Coloma; Barbara Schauble; Val J Lowe; Clifford R Jack; Ronald C Petersen
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

8.  Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Terry M Therneau; David S Knopman; Val Lowe; Prashanthi Vemuri; Michelle M Mielke; Rosebud O Roberts; Mary M Machulda; Matthew L Senjem; Jeffrey L Gunter; Walter A Rocca; Ronald C Petersen
Journal:  Lancet Neurol       Date:  2017-04-26       Impact factor: 44.182

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

10.  Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, APOE ε4, and Cognitive Impairment.

Authors:  Joseph Therriault; Tharick A Pascoal; Andrea L Benedet; Cecile Tissot; Melissa Savard; Mira Chamoun; Firoza Lussier; Min Su Kang; Gleb Berzgin; Tina Wang; Jaime Fernandes-Arias; Gassan Massarweh; Jean-Paul Soucy; Paolo Vitali; Paramita Saha-Chaudhuri; Serge Gauthier; Pedro Rosa-Neto
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910
  10 in total
  2 in total

1.  Electroacupuncture Improves Clearance of Amyloid-β through the Glymphatic System in the SAMP8 Mouse Model of Alzheimer's Disease.

Authors:  Pei-Zhe Liang; Li Li; Ya-Nan Zhang; Yan Shen; Li-Li Zhang; Jie Zhou; Zhi-Jie Wang; Shu Wang; Sha Yang
Journal:  Neural Plast       Date:  2021-08-26       Impact factor: 3.599

Review 2.  News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases.

Authors:  Jacopo Meldolesi
Journal:  Biomedicines       Date:  2021-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.